Montana SB535: Longevity and the Right to Try

The provided sources discuss Montana's new SB 535 bill, which significantly expands the existing "Right to Try" laws. This legislation now allows healthy individuals to access experimental longevity treatments that have not received final FDA approval, moving beyond the previous restriction to only terminally ill patients. The bill, signed into law on May 12, 2025, also mandates the establishment of licensed experimental treatment centers and requires patient informed consent, while also requiring centers to contribute a portion of their profits to support low-income patients. The sources highlight Montana's ambition to become a leader in life extension therapies and consider the potential for similar bills to emerge in other regions, with one source suggesting a "regional precision medical free zone" model for South Korea. While acknowledging the unproven nature and potential side effects of these treatments, the texts emphasize the significant opportunities this bill presents for researchers, medical professionals, and businesses in the longevity field, potentially redefining human lifespan.